Bringing innovation to the patient: SAMBA POC for HIV and Hepatitis

9 January 2023

ICASA Satellite symposium, Wednesday 4th December 2019, 18:30 – 20:30, Room Joel Nana (AD10)

This satellite symposium will focus on innovations in molecular point-of-care technologies for HIV and Hepatitis diagnosis. Field data of the game changing Leuco-depleted SAMBA viral load POC assay and the new SAMBA HCV assay will be presented, followed by interactive discussions with the audience on challenges and rewards of POC implementation.

Gary Brook, Central Middlesex Hospital, London, UK
Douglas Mangwanya, Department of Health and Child Care, Zimbabwe

Other Articles

Browse other related news and activities

Diagnostics for the Real World’s landmark SAMBA machine enters Science Museum Group’s permanent collection and features in major new “Injecting Hope” exhibition

Breakthrough SAMBA II point-of-care diagnostic machine on show to the public from this November, as part of inspiring COVID-19 science showcase.

4 March 2024

Diagnostics for the Real World’s multiplex respiratory virus rapid point-of-care tests approved for sale in New Zealand

SAMBA molecular diagnostic tests deliver fast “one sample, one test” detection of COVID-19, FluA/B and RSV in hospital, laboratory and non-laboratory settings.

4 March 2024

Transformative Role of SAMBA II in Winchester College’s COVID-19 Response

Many congratulations to Dr John Cullerne, Undermaster at Winchester College, whose pioneering work on COVID-19 was recognised recently with an invitation to Buckingham Palace.

4 March 2024